Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition

. 2015 May ; 32 (5) : 138. [epub] 20150324

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25801233

The aim of the present study is to evaluate the role of ATM (KU55933) and DNA-PK (NU7441) inhibitors in the repair of double-strand breaks and downstream signaling of DNA damage introduced by ionizing radiation. The irradiation of MCF-7 cells alone increased the proportion of cells in the G1 phase in comparison with mock-treated cells. After ATM inhibitor pretreatment, the cells were more accumulated in the G2 phase, whereas DNA-PK inhibitor application increased the percentage of cells in the G1 phase. ATM and DNA-PK inhibitor application alone increased the sensitivity of MCF-7 cells to ionizing radiation; however, combining both inhibitors together resulted in a further enhancement of cell death. Unexpectedly, combining both inhibitors decreased the percentage of senescent cells and increased G2 cell cycle arrest 3 days after treatment. After irradiation, the p21 protein was increased and Chk1 and Chk2 were activated. These proteins were not increased in cells pretreated with the ATM inhibitor prior to ionizing radiation exposure, albeit DNA-PK inhibitor application did not affect the amount of proteins detected. Formation of γH2AX was found to be ATM and DNA-PK dependent, application of the ATM inhibitor suppressed incidence of γH2AX, whereas DNA-PK caused persistence of γH2AX. Our results suggest that the further investigation of the ATM inhibitor in combination with the DNA-PK inhibitor as sensitizers preventing cell senescence and promoting cell death in breast carcinoma MCF-7 cells is warranted.

Zobrazit více v PubMed

Oncogene. 2011 Oct 13;30(41):4261-74 PubMed

Int J Radiat Biol. 2013 Jul;89(7):501-11 PubMed

Cell Cycle. 2013 Mar 1;12(5):773-82 PubMed

J Cell Biol. 2013 May 13;201(4):613-29 PubMed

Cell Cycle. 2010 Sep 1;9(17):3460-9 PubMed

Cancer Res. 2004 Dec 15;64(24):9152-9 PubMed

Br J Cancer. 1996 Mar;73(5):581-8 PubMed

Curr Opin Cell Biol. 2009 Apr;21(2):245-55 PubMed

DNA Repair (Amst). 2006 May 10;5(5):575-90 PubMed

PLoS One. 2013 Jul 11;8(7):e69061 PubMed

Nat Rev Cancer. 2003 Mar;3(3):155-68 PubMed

J Biol Chem. 2001 Nov 9;276(45):42462-7 PubMed

Cancer Res. 2004 Apr 1;64(7):2390-6 PubMed

Breast Cancer Res Treat. 2014 Jan;143(1):47-55 PubMed

Mutat Res. 2010 Apr-Jun;704(1-3):12-20 PubMed

Mol Cells. 2002 Apr 30;13(2):159-66 PubMed

Biochem Biophys Res Commun. 2009 Jan 23;378(4):847-50 PubMed

BMC Mol Biol. 2010 Mar 06;11:18 PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...